Top Stock Market Losers: ADTX, ICCT, CXAI, BDRX, NCNC

WISCONSIN (CoinChapter.com) — In August, the US added 187,000 jobs versus the 170,000 jobs experts predicted, while the unemployment rate increased to 3.8% versus 3.5% predicted.

Investors will now carefully examine the statistics to see how well the labor market is doing, fueling discussion over the Federal Reserve’s future interest rate path.

Here are the five stock market losers:

Aditxt Inc. (NASDAQ: ADTX)

Aditxt Inc. (NASDAQ: ADTX) specializes in developing and commercializing technologies for monitoring and modulating the immune system. Today’s only news was an announcement about definitive agreements for a private placement of 1,000,000 shares of common stock.

The shares are being offered at a purchase price of $10.00 per share with an accompanying warrant. Each share of common stock or pre-funded warrant is offered with additional purchase warrants in this placement.

iCoreConnect Inc. (NASDAQ: ICCT)

FG Financial Group Inc. announced the completion of its business combination with iCoreConnect Inc. (NASDAQ: ICCT) via its Merchant Banking platform, FG Merger Corp. The strategic move aligns with FG Financial Group’s focus on reinsurance and asset management, specifically in collateralized and loss-capped reinsurance.

iCoreConnect is a leader in cloud-based software and technology, but the news did not impress shareholders as they sold the stock today.

CXApp Inc. (NASDAQ: CXAI)

CXApp Inc. (NASDAQ: CXAI), the global pioneer in employee workplace experiences, announced no news today.

The company’s most recent release was its financial results for the second quarter of 2023 on Aug. 14, 2023. The main highlight of those results was the notable growth in new bookings, which saw an impressive rise of over 55% from Q2/2023.

The growth was driven by a strategic mix of expansions with existing customers and onboarding new ones. Furthermore, CXApp Inc. achieved significant efficiency in its operations, with a net reduction of 50% in operating expenses compared to pre-acquisition figures and a 25% reduction from the previous year.

Biodexa Pharmaceuticals PLC (NASDAQ: BDRX)

Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a clinical-stage biopharmaceutical company, had its most recent announcement five weeks ago when it launched a new corporate website. The site showcases Biodexa’s transition from a drug delivery technology organization to a drug development company.

With a primary focus on orphan and rare diseases, as well as oncology, Biodexa is committed to advancing the development of medications that provide patients with a better future. A significant aspect of this drug development process is the evaluation at the Clinical Trials site.

For no other reason than profit-taking, shareholders sold today.

noco-noco Pte. Ltd. (NASDAQ: NCNC)

Early-stage decarbonization solutions provider noco-noco Pte. Ltd. (NASDAQ: NCNC) and Prime Number Acquisition I Corp., a Delaware blank check company listed on NASDAQ, announced their intention one week ago to finalize their business combination.

This development is part of the companies’ commitment to expediting the global transition towards a carbon-neutral economy—shares sold today by 21.91%, with no other news to mention.